CVSS3
Attack Vector
PHYSICAL
Attack Complexity
HIGH
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
LOW
Integrity Impact
LOW
Availability Impact
HIGH
CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
EPSS
Percentile
20.0%
Successful exploitation of this vulnerability could allow an attacker to change configuration settings or disable the pump.
The following BD BodyGuard products are affected:
3.2.1 MISSING PROTECTION MECHANISM FOR ALTERNATE HARDWARE INTERFACE CWE-1299
The affected BD BodyGuard infusion pumps allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access and specialized equipment and knowledge could configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI), or personally identifiable information (PII) is stored in the pump.
CVE-2022-43557 has been assigned to this vulnerability. A CVSS v3 base score of 5.3 has been calculated; the CVSS vector string is (AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H).
BD reported this vulnerability to CISA.
BD recommends the following mitigations to reduce risk associated with this vulnerability:
For additional information, users should see BDβs security bulletin.
CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage at cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01BβTargeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.
No known public exploits specifically target this vulnerability. This vulnerability is not exploitable remotely. This vulnerability has a high attack complexity.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2022-43557
cisa.gov/ics
cisa.gov/ics
cisasurvey.gov1.qualtrics.com/jfe/form/SV_9n4TtB8uttUPaM6?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-335-01
cwe.mitre.org/data/definitions/1299.html
cwe.mitre.org/data/definitions/1299.html
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=BD%20BodyGuard%20Pumps+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-335-01
us-cert.cisa.gov/ics/Recommended-Practices
us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
www.bd.com/en-us/about-bd/cybersecurity/bulletin/bd-bodyguard-pumps-rs-232-interface-vulnerability
www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01
www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-335-01&title=BD%20BodyGuard%20Pumps
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-335-01
www.oig.dhs.gov/
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=BD%20BodyGuard%20Pumps&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-22-335-01